Home > Insider Trading > Filing (0001209191-19-007711)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1123494	Harvard Bioscience Inc	HBIO	Laboratory Analytical Instruments (3826)	043306140

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1400121	W James Green	C/O Harvard Bioscience, Inc. 84 October Hill Road Holliston MA 01746		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-08-29	2,500	$5.74	159,812	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $5.73 to $5.75. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes (a) a deferred stock award of 18,100 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 17, 2018, immediately prior to the commencement of such meeting, and (ii) May 17, 2019; (b) a deferred stock award of 11,250 restricted stock units which vest quarterly in equal installments on September 30, 2018 and December 31, 2018; and (c) 130,462 shares of common stock held by the Reporting Person.
This amendment is being filed to correct an administrative error by which 5,625 shares were inadvertently omitted from this amount in the reporting person's Form 4 filed on August 30, 2018 and subsequently omitted from the Form 4 filed on January 3, 2019.